Medicamen Organics Limited — Important, 18-03-2025: General Updates

Medicamen Organics Limited has successfully made a preferential allotment of 4,65,910 fully convertible warrants to promoter Mr. Bal Kishan Gupta at ₹64.39 each. This will strengthen the company's capital base, with 25% payable at allotment and the remaining 75% upon conversion into equity shares within 18 months. The capital raised will support Medicamen's expansion plans and market position, reflecting the promoter's confidence in the company's growth prospects. Mr. Gupta emphasized the pharmaceutical sector's steady growth and the company's commitment to enhancing its competitive edge and delivering high-quality solutions. This development could provide a positive outlook for investors as the company aims for operational efficiency and strategic growth in both local and international markets, including Africa and Southeast Asia.